Food as Medicine: An RCT to Study the Effect of Home Delivered, Medically Tailored Meals on Patients With Metastatic Cancer
The purpose of this study is to determine whether medically tailored meals (HDTM) can improve quality of life for patients with metastatic cancer.
Checked against the public recordLast updated Jun 9, 2020 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- NYU Langone Health
- Interventions being studied
- Other: Home Delivered, Medically Tailored Meals (HDTM)
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Diagnosis of pathologically confirmed metastatic pancreatic, hepatobiliary, esophageal, or lung cancer, either newly metastatic or metastatic at presentation (M1+) and enrollment within 6 weeks of diagnosis; measurable disease need not be present. * Pain Score (PS) 0-3 * Age\>18 * Both male and female subjects eligible * All ethnicities eligible * Access to refrigerator or freezer Exclusion Criteria: * Diagnosis of metastatic cancer no greater than 6 weeks prior to expected study enrollment * Currently receiving home delivered meals from other sources * Evidence of any alimentary tract obstruction or other condition preventing oral alimentation * Requirement for enteral or parenteral nutrition at time of diagnosis * Incarcerated individuals
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- NYU Perlmutter Cancer CenterNew York, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 9, 2020. Always confirm current availability with the study team.